| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetoscopy | 43 | 2025 | 447 | 9.140 |
Why?
|
| Meningomyelocele | 16 | 2025 | 250 | 6.940 |
Why?
|
| Neural Tube Defects | 14 | 2024 | 356 | 5.880 |
Why?
|
| Fetofetal Transfusion | 23 | 2024 | 194 | 3.750 |
Why?
|
| Hysterotomy | 14 | 2025 | 126 | 3.660 |
Why?
|
| Spinal Dysraphism | 9 | 2023 | 270 | 3.630 |
Why?
|
| Pregnancy | 86 | 2025 | 7222 | 3.430 |
Why?
|
| Gestational Age | 28 | 2025 | 1168 | 2.410 |
Why?
|
| Fetal Diseases | 11 | 2024 | 456 | 2.350 |
Why?
|
| Spina Bifida Cystica | 3 | 2024 | 35 | 2.340 |
Why?
|
| Hydrocephalus | 7 | 2024 | 245 | 2.330 |
Why?
|
| Prenatal Care | 8 | 2023 | 348 | 2.020 |
Why?
|
| Ultrasonography, Prenatal | 25 | 2024 | 972 | 1.900 |
Why?
|
| Magnetic Resonance Imaging | 14 | 2025 | 3603 | 1.800 |
Why?
|
| Infant, Newborn | 41 | 2025 | 8259 | 1.780 |
Why?
|
| Premature Birth | 8 | 2023 | 387 | 1.760 |
Why?
|
| Pregnancy, Twin | 19 | 2024 | 180 | 1.620 |
Why?
|
| Fetus | 16 | 2023 | 587 | 1.560 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 5 | 2025 | 399 | 1.550 |
Why?
|
| Fetal Growth Retardation | 6 | 2023 | 239 | 1.550 |
Why?
|
| Retrospective Studies | 51 | 2025 | 16435 | 1.490 |
Why?
|
| Delivery, Obstetric | 4 | 2023 | 252 | 1.480 |
Why?
|
| Walking | 2 | 2024 | 216 | 1.470 |
Why?
|
| Placenta Diseases | 2 | 2022 | 59 | 1.380 |
Why?
|
| Female | 89 | 2025 | 67028 | 1.360 |
Why?
|
| Pregnancy Outcome | 15 | 2024 | 595 | 1.340 |
Why?
|
| Carbon Dioxide | 7 | 2023 | 279 | 1.140 |
Why?
|
| Neurosurgical Procedures | 5 | 2021 | 306 | 1.030 |
Why?
|
| Laser Therapy | 9 | 2022 | 249 | 1.020 |
Why?
|
| Humans | 94 | 2025 | 125744 | 1.020 |
Why?
|
| Amniotic Fluid | 4 | 2024 | 151 | 0.990 |
Why?
|
| Placenta | 7 | 2023 | 509 | 0.990 |
Why?
|
| Urethral Obstruction | 3 | 2021 | 56 | 0.960 |
Why?
|
| Anemia | 3 | 2023 | 339 | 0.940 |
Why?
|
| Diseases in Twins | 2 | 2021 | 94 | 0.890 |
Why?
|
| Fetal Weight | 4 | 2023 | 61 | 0.890 |
Why?
|
| Fetal Membranes, Premature Rupture | 3 | 2021 | 60 | 0.880 |
Why?
|
| Adult | 39 | 2025 | 29759 | 0.870 |
Why?
|
| Prenatal Diagnosis | 8 | 2025 | 600 | 0.860 |
Why?
|
| Rh Isoimmunization | 1 | 2023 | 28 | 0.860 |
Why?
|
| Patient Simulation | 1 | 2023 | 39 | 0.810 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2020 | 50 | 0.810 |
Why?
|
| Insufflation | 3 | 2020 | 20 | 0.800 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2023 | 18 | 0.800 |
Why?
|
| Twins, Conjoined | 1 | 2023 | 29 | 0.800 |
Why?
|
| Balloon Occlusion | 1 | 2022 | 47 | 0.790 |
Why?
|
| Amnion | 2 | 2020 | 38 | 0.790 |
Why?
|
| Nervous System Malformations | 2 | 2023 | 130 | 0.790 |
Why?
|
| Corpus Callosum | 1 | 2022 | 98 | 0.780 |
Why?
|
| Child Development | 1 | 2025 | 266 | 0.780 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2022 | 62 | 0.770 |
Why?
|
| Fetal Death | 2 | 2022 | 112 | 0.770 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2025 | 505 | 0.760 |
Why?
|
| Fetal Development | 2 | 2024 | 132 | 0.760 |
Why?
|
| Brain | 6 | 2024 | 3009 | 0.760 |
Why?
|
| Umbilical Arteries | 6 | 2021 | 98 | 0.750 |
Why?
|
| Hemangioma | 1 | 2022 | 93 | 0.740 |
Why?
|
| Zika Virus Infection | 3 | 2018 | 171 | 0.730 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2019 | 81 | 0.720 |
Why?
|
| Rhombencephalon | 1 | 2021 | 49 | 0.720 |
Why?
|
| Motor Activity | 2 | 2021 | 520 | 0.720 |
Why?
|
| Laser Coagulation | 7 | 2024 | 129 | 0.720 |
Why?
|
| Hypothermia, Induced | 2 | 2019 | 170 | 0.700 |
Why?
|
| Wound Closure Techniques | 1 | 2020 | 23 | 0.690 |
Why?
|
| Cohort Studies | 15 | 2024 | 4853 | 0.690 |
Why?
|
| Simulation Training | 1 | 2022 | 140 | 0.690 |
Why?
|
| White Matter | 1 | 2022 | 184 | 0.680 |
Why?
|
| alpha-Fetoproteins | 1 | 2021 | 131 | 0.670 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 28 | 0.630 |
Why?
|
| Postoperative Complications | 6 | 2021 | 3080 | 0.610 |
Why?
|
| Uterus | 3 | 2019 | 568 | 0.610 |
Why?
|
| Lung | 3 | 2025 | 1496 | 0.610 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2018 | 455 | 0.610 |
Why?
|
| Obstetric Labor Complications | 2 | 2019 | 93 | 0.590 |
Why?
|
| Treatment Outcome | 13 | 2025 | 12425 | 0.570 |
Why?
|
| Pulsatile Flow | 4 | 2021 | 128 | 0.560 |
Why?
|
| Neuroimaging | 2 | 2019 | 341 | 0.530 |
Why?
|
| Ultrasonics | 1 | 2016 | 39 | 0.530 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 142 | 0.510 |
Why?
|
| Laparotomy | 3 | 2023 | 135 | 0.510 |
Why?
|
| Basal Ganglia | 1 | 2016 | 56 | 0.510 |
Why?
|
| Frontal Lobe | 1 | 2016 | 116 | 0.490 |
Why?
|
| Referral and Consultation | 1 | 2019 | 543 | 0.490 |
Why?
|
| Young Adult | 12 | 2021 | 9118 | 0.470 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 295 | 0.470 |
Why?
|
| Pregnancy Trimester, Second | 5 | 2021 | 166 | 0.450 |
Why?
|
| Kidney | 2 | 2024 | 1368 | 0.440 |
Why?
|
| Polycythemia | 3 | 2024 | 44 | 0.430 |
Why?
|
| Ultrasonography | 2 | 2019 | 941 | 0.410 |
Why?
|
| Predictive Value of Tests | 4 | 2021 | 2183 | 0.370 |
Why?
|
| Pleural Effusion | 2 | 2024 | 102 | 0.360 |
Why?
|
| Fetal Therapies | 3 | 2021 | 80 | 0.360 |
Why?
|
| Cerebrospinal Fluid Leak | 3 | 2021 | 43 | 0.350 |
Why?
|
| Texas | 5 | 2021 | 3588 | 0.340 |
Why?
|
| Airway Obstruction | 2 | 2023 | 165 | 0.320 |
Why?
|
| Postoperative Period | 2 | 2020 | 335 | 0.310 |
Why?
|
| Organ Size | 3 | 2025 | 441 | 0.310 |
Why?
|
| Ultrasonography, Doppler | 5 | 2020 | 195 | 0.300 |
Why?
|
| Lasers | 6 | 2024 | 114 | 0.290 |
Why?
|
| Infant | 9 | 2025 | 12597 | 0.290 |
Why?
|
| Lung Volume Measurements | 2 | 2025 | 75 | 0.290 |
Why?
|
| Microcephaly | 3 | 2018 | 331 | 0.260 |
Why?
|
| Blood Transfusion, Intrauterine | 2 | 2023 | 37 | 0.260 |
Why?
|
| Societies, Medical | 2 | 2021 | 699 | 0.260 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1334 | 0.250 |
Why?
|
| Male | 11 | 2025 | 61807 | 0.250 |
Why?
|
| Hypoplastic Left Heart Syndrome | 2 | 2019 | 257 | 0.250 |
Why?
|
| Extraembryonic Membranes | 1 | 2024 | 14 | 0.230 |
Why?
|
| Mechanical Phenomena | 1 | 2024 | 16 | 0.230 |
Why?
|
| Sacrococcygeal Region | 1 | 2024 | 32 | 0.230 |
Why?
|
| Trachea | 2 | 2023 | 203 | 0.230 |
Why?
|
| Twins, Monozygotic | 5 | 2023 | 117 | 0.230 |
Why?
|
| Child, Preschool | 4 | 2024 | 14140 | 0.220 |
Why?
|
| Sutures | 1 | 2024 | 65 | 0.220 |
Why?
|
| Prospective Studies | 5 | 2024 | 6173 | 0.210 |
Why?
|
| Teratoma | 1 | 2024 | 125 | 0.210 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2023 | 49 | 0.210 |
Why?
|
| Abruptio Placentae | 1 | 2022 | 16 | 0.200 |
Why?
|
| Fetal Blood | 1 | 2023 | 177 | 0.200 |
Why?
|
| Cervix Uteri | 1 | 2023 | 64 | 0.200 |
Why?
|
| Edema | 1 | 2023 | 136 | 0.200 |
Why?
|
| Microarray Analysis | 1 | 2023 | 238 | 0.200 |
Why?
|
| Pregnancy, Triplet | 1 | 2022 | 10 | 0.200 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 51 | 0.200 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 275 | 0.200 |
Why?
|
| Hydrops Fetalis | 1 | 2022 | 74 | 0.200 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 2918 | 0.190 |
Why?
|
| Cesarean Section | 3 | 2019 | 389 | 0.190 |
Why?
|
| Cesarean Section, Repeat | 1 | 2021 | 8 | 0.190 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2024 | 373 | 0.180 |
Why?
|
| Body Composition | 1 | 2024 | 521 | 0.180 |
Why?
|
| Incidence | 4 | 2021 | 3155 | 0.180 |
Why?
|
| Waist Circumference | 1 | 2021 | 89 | 0.180 |
Why?
|
| Surgical Instruments | 1 | 2021 | 56 | 0.180 |
Why?
|
| Labor, Induced | 1 | 2021 | 34 | 0.180 |
Why?
|
| Magnesium Sulfate | 1 | 2021 | 48 | 0.180 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2022 | 240 | 0.180 |
Why?
|
| Birth Weight | 2 | 2020 | 345 | 0.170 |
Why?
|
| Adolescent | 6 | 2021 | 19478 | 0.170 |
Why?
|
| Preoperative Period | 1 | 2020 | 88 | 0.170 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2024 | 319 | 0.170 |
Why?
|
| Uterine Rupture | 1 | 2020 | 18 | 0.170 |
Why?
|
| Abortion, Spontaneous | 1 | 2021 | 80 | 0.170 |
Why?
|
| Myometrium | 1 | 2020 | 47 | 0.170 |
Why?
|
| Delphi Technique | 1 | 2021 | 210 | 0.170 |
Why?
|
| Polytetrafluoroethylene | 1 | 2020 | 84 | 0.170 |
Why?
|
| Gastroschisis | 1 | 2020 | 54 | 0.170 |
Why?
|
| Epidemics | 2 | 2018 | 54 | 0.170 |
Why?
|
| Uterine Contraction | 1 | 2019 | 28 | 0.160 |
Why?
|
| Amniotic Band Syndrome | 1 | 2020 | 24 | 0.160 |
Why?
|
| Pregnancy Complications | 2 | 2021 | 514 | 0.160 |
Why?
|
| Urologic Diseases | 1 | 2019 | 44 | 0.160 |
Why?
|
| Thulium | 1 | 2019 | 6 | 0.160 |
Why?
|
| Choroid Plexus | 1 | 2019 | 23 | 0.160 |
Why?
|
| Cicatrix | 1 | 2020 | 124 | 0.160 |
Why?
|
| Lymphatic Vessels | 1 | 2019 | 37 | 0.160 |
Why?
|
| Ventriculostomy | 1 | 2019 | 36 | 0.160 |
Why?
|
| Preoperative Care | 1 | 2021 | 355 | 0.150 |
Why?
|
| Intraoperative Care | 1 | 2019 | 106 | 0.150 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2018 | 9 | 0.150 |
Why?
|
| Cost-Benefit Analysis | 1 | 2021 | 513 | 0.150 |
Why?
|
| Postnatal Care | 1 | 2019 | 51 | 0.150 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2019 | 50 | 0.150 |
Why?
|
| Hot Temperature | 1 | 2019 | 137 | 0.150 |
Why?
|
| Workflow | 1 | 2019 | 118 | 0.150 |
Why?
|
| Lymphatic Abnormalities | 1 | 2019 | 34 | 0.150 |
Why?
|
| Movement Disorders | 1 | 2021 | 222 | 0.150 |
Why?
|
| Cerebrovascular Circulation | 2 | 2018 | 463 | 0.150 |
Why?
|
| Light Coagulation | 3 | 2023 | 24 | 0.150 |
Why?
|
| Perinatal Care | 1 | 2019 | 67 | 0.150 |
Why?
|
| Trial of Labor | 1 | 2018 | 21 | 0.150 |
Why?
|
| Oxytocics | 1 | 2018 | 28 | 0.150 |
Why?
|
| Oxygen | 2 | 2018 | 557 | 0.150 |
Why?
|
| Subarachnoid Space | 1 | 2018 | 24 | 0.150 |
Why?
|
| Evoked Potentials, Visual | 1 | 2018 | 35 | 0.150 |
Why?
|
| Colombia | 1 | 2018 | 48 | 0.150 |
Why?
|
| Neck | 1 | 2019 | 135 | 0.150 |
Why?
|
| Oxytocin | 1 | 2018 | 68 | 0.140 |
Why?
|
| Vascular Resistance | 1 | 2018 | 189 | 0.140 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2018 | 53 | 0.140 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2019 | 118 | 0.140 |
Why?
|
| Labor, Obstetric | 1 | 2018 | 94 | 0.140 |
Why?
|
| Cerebrospinal Fluid | 1 | 2018 | 94 | 0.140 |
Why?
|
| Program Evaluation | 1 | 2019 | 443 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 265 | 0.140 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 192 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1701 | 0.140 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2016 | 18 | 0.140 |
Why?
|
| Models, Animal | 1 | 2019 | 464 | 0.130 |
Why?
|
| Endoscopy | 1 | 2019 | 281 | 0.130 |
Why?
|
| Logistic Models | 1 | 2021 | 1817 | 0.130 |
Why?
|
| Sepsis | 1 | 2021 | 482 | 0.130 |
Why?
|
| Global Health | 1 | 2021 | 567 | 0.130 |
Why?
|
| Calcinosis | 1 | 2018 | 179 | 0.130 |
Why?
|
| Zika Virus | 1 | 2018 | 144 | 0.130 |
Why?
|
| Pregnancy Trimester, First | 1 | 2016 | 114 | 0.130 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2017 | 63 | 0.130 |
Why?
|
| Ovary | 1 | 2018 | 380 | 0.120 |
Why?
|
| Intubation, Intratracheal | 1 | 2019 | 287 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2018 | 280 | 0.120 |
Why?
|
| Movement | 1 | 2016 | 172 | 0.120 |
Why?
|
| Chromosome Disorders | 1 | 2016 | 311 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1274 | 0.110 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3313 | 0.090 |
Why?
|
| Risk Factors | 3 | 2021 | 10341 | 0.090 |
Why?
|
| Twins | 2 | 2021 | 69 | 0.090 |
Why?
|
| Iatrogenic Disease | 2 | 2022 | 133 | 0.090 |
Why?
|
| Biomarkers | 1 | 2019 | 3097 | 0.080 |
Why?
|
| Infant Mortality | 2 | 2019 | 174 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2021 | 1522 | 0.070 |
Why?
|
| Regression Analysis | 2 | 2020 | 781 | 0.070 |
Why?
|
| Middle Aged | 3 | 2021 | 27002 | 0.070 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2019 | 316 | 0.060 |
Why?
|
| Humidity | 1 | 2024 | 25 | 0.060 |
Why?
|
| Tensile Strength | 1 | 2024 | 40 | 0.060 |
Why?
|
| Pressure | 1 | 2024 | 131 | 0.060 |
Why?
|
| Polyesters | 1 | 2024 | 39 | 0.060 |
Why?
|
| Materials Testing | 1 | 2024 | 73 | 0.060 |
Why?
|
| Cerebral Ventricles | 1 | 2024 | 82 | 0.060 |
Why?
|
| Arm | 1 | 2024 | 81 | 0.050 |
Why?
|
| Temperature | 1 | 2024 | 307 | 0.050 |
Why?
|
| Biomechanical Phenomena | 1 | 2024 | 245 | 0.050 |
Why?
|
| Fetal Heart | 1 | 2024 | 120 | 0.050 |
Why?
|
| Animals | 2 | 2024 | 34367 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2023 | 239 | 0.050 |
Why?
|
| Maryland | 1 | 2021 | 30 | 0.050 |
Why?
|
| Pregnancy Reduction, Multifetal | 1 | 2021 | 20 | 0.050 |
Why?
|
| Fetal Movement | 1 | 2021 | 14 | 0.050 |
Why?
|
| Clubfoot | 1 | 2021 | 19 | 0.050 |
Why?
|
| Umbilical Cord | 1 | 2021 | 56 | 0.050 |
Why?
|
| Encephalocele | 1 | 2021 | 51 | 0.040 |
Why?
|
| Prognosis | 2 | 2021 | 4700 | 0.040 |
Why?
|
| North America | 1 | 2021 | 242 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2021 | 436 | 0.040 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2020 | 57 | 0.040 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2021 | 81 | 0.040 |
Why?
|
| Placental Circulation | 1 | 2020 | 24 | 0.040 |
Why?
|
| Live Birth | 1 | 2020 | 55 | 0.040 |
Why?
|
| Heart Arrest | 1 | 2024 | 357 | 0.040 |
Why?
|
| Perinatal Mortality | 1 | 2019 | 43 | 0.040 |
Why?
|
| Models, Biological | 1 | 2024 | 1469 | 0.040 |
Why?
|
| Oligohydramnios | 1 | 2019 | 46 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 760 | 0.040 |
Why?
|
| Infant Care | 1 | 2019 | 46 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2019 | 74 | 0.040 |
Why?
|
| Umbilical Veins | 1 | 2019 | 73 | 0.040 |
Why?
|
| Stomach | 1 | 2021 | 270 | 0.040 |
Why?
|
| Perioperative Care | 1 | 2021 | 195 | 0.040 |
Why?
|
| Portal Vein | 1 | 2019 | 93 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2018 | 104 | 0.040 |
Why?
|
| Parturition | 1 | 2019 | 63 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 81 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2021 | 1261 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2024 | 1014 | 0.040 |
Why?
|
| Patient Admission | 1 | 2019 | 185 | 0.040 |
Why?
|
| Norwood Procedures | 1 | 2019 | 101 | 0.040 |
Why?
|
| Mass Screening | 1 | 2023 | 787 | 0.030 |
Why?
|
| Pulmonary Veins | 1 | 2019 | 161 | 0.030 |
Why?
|
| Liver | 1 | 2024 | 1749 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 68 | 0.030 |
Why?
|
| Anxiety | 1 | 2023 | 956 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 409 | 0.030 |
Why?
|
| Heart Atria | 1 | 2019 | 316 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2018 | 241 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2018 | 764 | 0.030 |
Why?
|
| Echocardiography | 1 | 2021 | 1060 | 0.030 |
Why?
|
| Length of Stay | 1 | 2021 | 1313 | 0.030 |
Why?
|
| Depression | 1 | 2023 | 1239 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 1398 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 622 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 1902 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 2090 | 0.030 |
Why?
|
| Stents | 1 | 2019 | 889 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 724 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 3470 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2905 | 0.020 |
Why?
|
| United States | 1 | 2021 | 10938 | 0.020 |
Why?
|
| Child | 1 | 2023 | 24608 | 0.010 |
Why?
|